» Articles » PMID: 28676761

Asymmetrical Polymer Vesicles for Drug Delivery and Other Applications

Overview
Journal Front Pharmacol
Date 2017 Jul 6
PMID 28676761
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Scientists have been attracted by polymersomes as versatile drug delivery systems since the last two decades. Polymersomes have the potential to be versatile drug delivery systems because of their tunable membrane formulations, stabilities , various physicochemical properties, controlled release mechanisms, targeting abilities, and capacities to encapsulate a wide range of drugs and other molecules. Asymmetrical polymersomes are nano- to micro-sized polymeric capsules with asymmetrical membranes, which means, they have different outer and inner coronas so that they can exhibit better endocytosis rate and endosomal escape ability than other polymeric systems with symmetrical membranes. Hence, asymmetrical polymersomes are highly promising as self-assembled nano-delivery systems in the future for therapeutics delivery and diagnostic imaging applications. In this review, we prepared a summary about recent research progresses of asymmetrical polymersomes in the following aspects: synthesis, preparation, applications in drug delivery and others.

Citing Articles

Application of nanoparticles in breast cancer treatment: a systematic review.

Bourang S, Noruzpour M, Jahanbakhsh Godekahriz S, Ebrahimi H, Amani A, Asghari Zakaria R Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6459-6505.

PMID: 38700795 DOI: 10.1007/s00210-024-03082-y.


Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy.

Negut I, Bita B Pharmaceutics. 2024; 16(4).

PMID: 38675124 PMC: 11053450. DOI: 10.3390/pharmaceutics16040463.


Unraveling the Phase Behavior, Mechanical Stability, and Protein Reconstitution Properties of Polymer-Lipid Hybrid Vesicles.

Muller W, Beales P, Muniz A, Jeuken L Biomacromolecules. 2023; 24(9):4156-4169.

PMID: 37539954 PMC: 10498451. DOI: 10.1021/acs.biomac.3c00498.


Application of polymersomes in membrane protein study and drug discovery: Progress, strategies, and perspectives.

Lo C, Zeng J Bioeng Transl Med. 2023; 8(1):e10350.

PMID: 36684106 PMC: 9842050. DOI: 10.1002/btm2.10350.


A Review of Polymeric Micelles and Their Applications.

Perumal S, Atchudan R, Lee W Polymers (Basel). 2022; 14(12).

PMID: 35746086 PMC: 9230755. DOI: 10.3390/polym14122510.


References
1.
Hvasanov D, Wiedenmann J, Braet F, Thordarson P . Induced polymersome formation from a diblock PS-b-PAA polymer via encapsulation of positively charged proteins and peptides. Chem Commun (Camb). 2011; 47(22):6314-6. DOI: 10.1039/c1cc11662b. View

2.
Kim S, Foote M, Huang L . The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticles. Biomaterials. 2012; 33(15):3959-66. PMC: 3307951. DOI: 10.1016/j.biomaterials.2012.02.010. View

3.
Schrama D, Reisfeld R, Becker J . Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov. 2006; 5(2):147-59. DOI: 10.1038/nrd1957. View

4.
Christian D, Cai S, Bowen D, Kim Y, Pajerowski J, Discher D . Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm. 2008; 71(3):463-74. PMC: 2702089. DOI: 10.1016/j.ejpb.2008.09.025. View

5.
Meng F, Zhong Y, Cheng R, Deng C, Zhong Z . pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances. Nanomedicine (Lond). 2014; 9(3):487-99. DOI: 10.2217/nnm.13.212. View